OSCR Oscar Health, Inc. Class A Common Stock

NYSE · Insurance · 在 SEC EDGAR 上查看 ↗
$31.51
价格 · 八月 19, 2026
截至...的财报数据 八月 7, 2026

关于 Oscar Health, Inc. Class A Common Stock 公司概况(来自维基百科)

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

阅读更多

Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company sells health insurance and additionally provides other services in the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems.

History

2012–2015

According to the company, it was founded in 2012 by Mario Schlosser, Joshua Kushner, and Kevin Nazemi, who were classmates at Harvard Business School. Mother Jones reported in March 2020 that Joshua and his brother Jared owned the firm's parent company, Thrive Partners III, at the time of its incorporation in 2013. Oscar began selling insurance for 2013, the same year that the Affordable Care Act exchanges and individual mandate went into effect for the 2014 plan year. In its first year, Oscar secured 16,000 members. In 2015, Oscar expanded coverage to New Jersey and grew to about 40,000 members.

2016

Oscar had 145,000 members in New York, New Jersey, California, and Texas in 2016. The firm expanded its operations to Tempe, Arizona, in August that year, where it decided to locate its Concierge teams, their name for their member services model. On August 23, Oscar announced it would be exiting the New Jersey Marketplace at the end of 2016, citing uncertainties in the market that would make it challenging "to operate effectively and continue to deliver access to quality healthcare." Oscar also announced that it would halve the size of its provider network in New York amidst rising premiums in order to "gain more control over pricing and patient experience".

In November 2016, the firm opened the Oscar Center in partnership with Mount Sinai Health System. Located in Brooklyn Heights, next to the Jay Street–MetroTech station, the Oscar Center had a primary care practice only available to Oscar policyholders, with a doctor, nurse practitioner, and a behavioral health specialist. It also hosted free classes for members, such as yoga classes or classes for expectant mothers. On March 13, 2020, Oscar closed the Oscar Center "until further notice."

2017

On April 25, 2017, Oscar announced its entrance into the small group insurance market, offering health plans in New York. On June 15, 2017, Oscar announced its partnership with Cleveland Clinic to offer individual health insurance plans to consumers in five counties in Northeastern Ohio.

On June 21, 2017, Oscar announced its intention to expand to additional markets in 2018 in areas of Tennessee, Ohio, Texas, New Jersey and California. On July 12, 2017, Oscar announced that it would be selling small group insurance in the Nashville metro area to companies with up to 50 employees through a strategic partnership with Humana.

A report by the New York Times in October 2017 speculated that Oscar Health had ties to Saudi Arabia. That month, Jared and Joshua Kushner visited Saudi Arabia's Crown Prince Mohammed bin Salman within days of each other. Despite Jared severing ties with Thrive Partners when he began working for the Trump administration, these coordinated visits raised questions about his ability to be impartial on Saudi affairs. Five months after Joshua's visit to Saudi Arabia in October 2017, Oscar Health announced a $165 million round of financing.

While a spokesman for Kushner said that Oscar Health's management didn't know of direct investment by the Saudis, he declined to disclose if Saudis had invested in Thrive funds. He only confirmed that Thrive hadn't received money from any Saudi parties since the presidential election. In May 2018, Jared Kushner disclosed $8.2 million in capital gains from Thrive funds.

2020–present

In January 2020, Oscar announced a partnership with Cigna to bring health insurance plans to small businesses. The partnership, Cigna + Oscar, will "launch in select markets in 2020 and plan to expand the partnership over time."

As of June 2020, Oscar had sold individual health insurance plans, both directly and through health insurance marketplaces, in New York, Texas and California. Oscar sells Medicare Advantage plans in New York City and Houston, Texas. Mario Schlosser is the company's CEO, after serving as Co-CEO with Nazemi until the latter's departure in early 2015. While Kushner does not hold a formal role in Oscar's daily operations, he remains a major shareholder and Schlosser confirmed (as of 2017) that he has "significant input in multiple aspects of the company like strategy, hiring, and marketing."

Oscar Health raised $1.2 billion on March 3, 2021, after an IPO.

Oscar Health reported 1.1 million members across its platform, which equates to 1 in 13 ACA exchange-based enrollees. The company announced it would exit the Arkansas and Colorado markets for plan year 2023.

Mario Schlosser steps down as CEO on April 3, 2023, transitioning to President of Technology. Mark Bertolini takes over as CEO. [1]

In 2025, Oscar Health was ranked 437th by revenue on the Fortune 500 list and 42nd within the healthcare sector in the same rankings.

Marketing and brand

Oscar Health has run marketing campaigns on the New York City Subway. Bloomberg News reported the advertising campaigns feature cartoons suggesting "an easier way of getting medical care." AdWeek described Oscar Health's print ads as featuring "whimsical, animated characters".

In 2015, AdWeek reported that Oscar was airing its first television campaign targeted at the demographics of "new parents who are too frazzled to shop for health insurance." The ad launched on network stations in New Jersey and New York areas, cable, movie theaters located in New Jersey and in advertising within the Spotify app.

In 2016, Oscar ran a subway ad campaign with an educational bent around what the problems are with the American healthcare system.

Finances

Funding

Oscar has raised capital through a series of funding rounds. Its investors include Thrive Capital, General Catalyst Partners, Khosla Ventures, CapitalG, and Fidelity Investments.

During the May 2014 Series A round, Peter Thiel's Founders Fund led the series investing $30 million. By the close of Series A, Forbes reported the valuation of the company at $800 million.

During the 2015 Series B round, Oscar Health raised $145 million, bringing the total capital raised to $300 million, thus valuing the company at $1.5 billion. Series B investors included Formation 8, Horizons Ventures, Wellington Management Company, and Goldman Sachs.

In September 2015, Oscar announced a funding round with Google Ventures and Google Capital, valuing the company at $1.75 billion.

During the 2016 Series C round, Oscar raised $400 million led by Fidelity Investments, with secondary participation from previous investors, with a reported valuation of $2.7 billion. In 2018, Alphabet invested $375 million in Oscar Health. As of 2019, the company had raised $1.3 billion, and was valued at $3.2 billion.

In June 2020, Oscar raised $225 million in funding, in which the funding round saw participation from previous investors and also new investors, namely Baillie Gifford and Coatue.

Revenue

In 2014, New York magazine reported that as of May 2014, Oscar Health had 16,000 subscribers enrolled in its insurance program producing an estimated $72 million. In 2015, Forbes reported that Oscar Health had 40,000 subscribers with an average subscriber paying annual fees of $4,500, placing Oscar Health's revenue estimates at $180 million.

Vox reported that in 2015, Oscar Health lost $92.4 million in New York as the firm's analytical models failed to accurately forecast "the people who signed up for coverage were sicker than the company had expected."

By 2016, Oscar Health had 135,000 subscribers, with roughly half residing in New York State.

In February 2017, Bloomberg reported that Oscar had lost $204.9 million in 2016.

In May 2017, Bloomberg reported that Oscar's first quarter loss had narrowed by nearly half, writing that the company was "beginning to get a handle on its medical costs." In August 2017, Bloomberg also reported that Oscar had posted a $57.6 million loss in the first half of 2017, down from the $83 million lost posted the year prior.

In December 2017, TechCrunch reported that Oscar would expect to generate $1 billion in revenue and enroll 250,000 in 2018.

In January 2020, TechCrunch reported that Oscar served 400,000 members and expected to bring in $2 billion by the end of the year.

Headquarters and offices

Oscar's headquarters are located in Tribeca, New York City. They also have a technology outpost in Los Angeles and a member services operation in Tempe, Arizona.

来源:维基百科 (英语), CC BY-SA 4.0 · 在维基百科上查看 ↗

Wikidata ↗

OSCR 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围

价格
$31.51
市值
P/E (TTM)
-8.5
每股收益 (TTM)
$-1.69
营收 (TTM)
$11.70B
股息收益率
ROE
-44.5%
负债/权益
0.4
52周区间
$11 – $33

OSCR 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图

10年表现 收入、净利润、利润率和每股收益趋势

营收与净利润 $11.70B
7-point trend, +2296.9%
2019-12-31 2025-12-31
EPS $-1.69
7-point trend, +81.3%
2019-12-31 2025-12-31
自由现金流 $1.06B
4-point trend, +609.8%
2021-12-31 2025-12-31
利润率 -3.8%

估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?

指标
5年趋势
OSCR
同行中位数
P/E (TTM)
5-point trend, -246.6%
-8.5
13.5

盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)

指标
5年趋势
OSCR
同行中位数
Operating Margin (营业利润率)
4-point trend, +88.6%
-3.4%
Net Profit Margin (净利润率)
4-point trend, +87.8%
-3.8%
5.4%
ROA
4-point trend, +61.2%
-7.9%
0.55%
ROE
4-point trend, -21.3%
-44.5%
8.0%
ROIC
4-point trend, +27.4%
-28.5%

财务健康 债务、流动性、偿付能力 — 资产负债表强度

指标
5年趋势
OSCR
同行中位数
Debt / Equity (负债/股东权益比率)
4-point trend, +0.44
0.4
Current Ratio (流动比率)
4-point trend, -23.8%
0.9
0.1
Quick Ratio (速动比率)
4-point trend, -4.3%
0.6

成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)

指标
5年趋势
OSCR
同行中位数
Revenue YoY (营收同比增长)
5-point trend, +536.4%
27.5%
Revenue CAGR 3Y (营收3年复合年增长率)
5-point trend, +536.4%
43.5%
Revenue CAGR 5Y (营收5年复合年增长率)
5-point trend, +536.4%
90.8%

每股指标 每股收益 (EPS)、每股净资产、每股现金流、每股股息

指标
5年趋势
OSCR
同行中位数
EPS (Diluted) (EPS (稀释))
5-point trend, +47.2%
$-1.69

资本效率 资产周转率、库存周转率、应收账款周转率

指标
5年趋势
OSCR
同行中位数

OSCR 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间

买入 19 位分析师
  • 强烈买入 2 10.5%
  • 买入 7 36.8%
  • 持有 9 47.4%
  • 卖出 1 5.3%
  • 强烈卖出 0 0.0%

12个月价格目标

10 位分析师 · 2026-08-15
中位数目标 $28.50 -9.6%
平均目标 $29.00 -8.0%

收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期

平均惊喜
0.16%
期间 EPS Actual EPS 预期 惊喜
2026年6月30日 $1.10 $0.39 0.71%
2026年3月31日 $2.07 $1.21 0.86%
2025年12月31日 $-1.24 $-0.91 -0.33%
2025年9月30日 $-0.53 $-0.57 0.04%
2025年6月30日 $-0.89 $-0.47 -0.42%
2025年3月31日 $0.92 $0.81 0.11%

同行比较(GICS 子行业) 关键指标与行业同行对比

股票代码 市值 P/E 营收同比增长 净利润率 ROE 毛利率
OSCR -8.5 27.5% -3.8% -44.5%
PRU
PFG $19.18B 16.8 -3.1% 7.6% 10.3%
UNM
GL $12.90B 9.9 3.7% 19.4% 20.4%
PRI $8.22B 11.3 6.6% 22.8% 31.9%
LNC $8.46B 7.6 -1.2% 6.5% 12.3%
CNO $4.01B 18.5 0.85% 5.1% 8.9%
GNW $3.54B 16.7 0.08% 3.0% 2.6%

完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表

损益表 13
OSCR 的年度损益表数据
指标 趋势 202520242023202220212020
Revenue 6-point trend, +2428.4% $11.70B $9.18B $5.86B $3.96B $1.84B $463M
SG&A Expense 6-point trend, +1130.0% $2.05B $1.76B $1.43B $1.26B $265M $167M
Operating Income 6-point trend, +1.5% $-396M $57M $-236M $-590M $-544M $-402M
Interest Expense 4-point trend, +600.1% · · $25M $23M $5M $4M
Other Non-op 5-point trend, -1843.3% $-23M $-105.0K $-7M $2M $-1M ·
Pretax Income 6-point trend, -7.8% $-437M $33M $-267M $-610M $-571M $-406M
Income Tax 6-point trend, +436.5% $6M $7M $3M $-523.0K $846.0K $1M
Net Income 6-point trend, -8.9% $-443M $25M $-271M $-606M $-573M $-407M
EPS (Basic) 6-point trend, +88.1% $-1.69 $0.11 $-1.22 $-2.85 $-3.20 $-14.16
EPS (Diluted) 6-point trend, +88.1% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 $-14.16
Shares (Basic) 6-point trend, +796.6% 262,388,000 240,386,000 221,655,000 212,475,000 178,967,056 29,263,424
Shares (Diluted) 6-point trend, +796.6% 262,388,000 265,853,000 221,655,000 212,475,000 178,967,056 29,263,424
EBITDA 4-point trend, +30.7% $-367M $89M $-205M · $-530M ·
资产负债表 23
OSCR 的年度资产负债表数据
指标 趋势 202520242023202220212020
Cash & Equivalents 6-point trend, +235.7% $2.77B $1.53B $1.87B $1.56B $1.10B $826M
Short-term Investments 2-point trend, -9.5% · $624M $690M · · ·
Receivables $363M · · · · ·
Other Current Assets 5-point trend, +543.3% $24M $21M $7M $6M $4M ·
Current Assets 6-point trend, +146.6% $4.61B $2.85B $3.06B $4.12B $2.31B $1.87B
PP&E (Net) 6-point trend, +146.7% $88M $67M $62M $60M $47M $36M
PP&E (Gross) 6-point trend, +263.3% $230M $181M $150M $117M $89M $63M
Accum. Depreciation 6-point trend, +415.1% $142M $114M $88M $57M $42M $27M
Other Non-current Assets 6-point trend, +811.4% $120M $82M $83M $95M $97M $13M
Total Assets 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
Accounts Payable 6-point trend, +268.9% $507M $432M $273M $298M $235M $138M
Current Liabilities 6-point trend, +191.9% $4.86B $3.46B $2.43B $3.26B $1.85B $1.67B
Capital Leases 5-point trend, -32.3% $52M $61M $67M $72M $77M ·
Other Non-current Liabilities 6-point trend, +51994000.00 $52M $61M $68M $72M $77M $0
Total Liabilities 6-point trend, +193.2% $5.34B $3.82B $2.80B $3.63B $1.93B $1.82B
Total Debt 4-point trend, +430095000.00 $430M $300M $299M · $0 ·
Common Stock · · · · · $2.0K
Paid-in Capital 6-point trend, +3094.6% $4.26B $3.87B $3.68B $3.51B $3.39B $133M
Retained Earnings 6-point trend, -130.8% $-3.29B $-2.85B $-2.88B $-2.61B $-2.00B $-1.43B
Treasury Stock Flat — no change across 6 periods $3M $3M $3M $3M $3M $3M
AOCI 6-point trend, +1951.2% $18M $-2M $1M $-10M $-4M $879.0K
Stockholders' Equity 6-point trend, +175.4% $978M $1.01B $804M $890M $1.39B $-1.30B
Liabilities + Equity 6-point trend, +178.4% $6.33B $4.84B $3.60B $4.53B $3.32B $2.27B
现金流 16
OSCR 的年度现金流数据
指标 趋势 202520242023202220212020
D&A 6-point trend, +156.0% $29M $32M $31M $15M $15M $11M
Stock-based Comp 6-point trend, +144.4% $88M $110M $160M $112M $86M $36M
Deferred Tax 6-point trend, +3755.2% $2M $-2M $58.0K $-165.0K $-101.0K $-67.0K
Other Non-cash 4-point trend, +389.2% $1.42B $813M $-192M · $290M ·
Operating Cash Flow 6-point trend, +391.6% $1.09B $978M $-272M $380M $-182M $223M
CapEx 6-point trend, +159.4% $36M $28M $26M $29M $26M $14M
Investing Cash Flow 6-point trend, +30.1% $-241M $-1.39B $577M $-227M $-775M $-345M
Debt Issued 6-point trend, +178.9% $410M $0 $0 $305M $0 $147M
Net Debt Issued 3-point trend, +410000000.00 $410M $0 $0 · · ·
Stock Repurchased Flat — no change across 2 periods · · · · $0 $0
Net Stock Activity · · · · $0 ·
Financing Cash Flow 6-point trend, -34.7% $399M $68M $6M $301M $1.24B $612M
Net Change in Cash 6-point trend, +155.9% $1.25B $-341M $311M $455M $282M $490M
Taxes Paid 6-point trend, +1048.6% $18M $674.0K $2M $2M $697.0K $2M
Free Cash Flow 4-point trend, +609.8% $1.06B $950M $-298M · $-208M ·
Levered FCF 2-point trend, -51.9% · · $-323M · $-212M ·
盈利能力 7
OSCR 的年度盈利能力数据
指标 趋势 202520242023202220212020
Operating Margin 4-point trend, +88.6% -3.4% 0.62% -4.0% · -29.6% ·
Net Margin 4-point trend, +87.8% -3.8% 0.28% -4.6% · -31.1% ·
Pretax Margin 4-point trend, +87.9% -3.7% 0.36% -4.6% · -31.0% ·
EBITDA Margin 4-point trend, +89.1% -3.1% 0.97% -3.5% · -28.8% ·
ROA 4-point trend, +61.2% -7.9% 0.60% -6.7% · -20.5% ·
ROE 4-point trend, -21.3% -44.5% 2.8% -32.0% · -36.7% ·
ROIC 4-point trend, +27.4% -28.5% 3.4% -21.6% · -39.3% ·
流动性与偿付能力 5
OSCR 的年度流动性与偿付能力数据
指标 趋势 202520242023202220212020
Current Ratio 4-point trend, -23.8% 0.9 0.8 1.3 · 1.2 ·
Quick Ratio 4-point trend, -4.3% 0.6 0.6 0.8 · 0.6 ·
Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
LT Debt / Equity 4-point trend, +0.44 0.4 0.3 0.4 · 0.0 ·
Interest Coverage 2-point trend, +91.7% · · -9.6 · -115.4 ·
效率 1
OSCR 的年度效率数据
指标 趋势 202520242023202220212020
Asset Turnover 4-point trend, +218.8% 2.1 2.2 1.4 · 0.7 ·
每股 3
OSCR 的年度每股数据
指标 趋势 202520242023202220212020
Revenue / Share 4-point trend, +334.1% $44.60 $34.52 $26.45 · $10.27 ·
Cash Flow / Share 4-point trend, +510.9% $4.17 $3.68 $-1.23 · $-1.02 ·
EPS (TTM) 5-point trend, +47.2% $-1.69 $0.10 $-1.22 $-2.85 $-3.20 ·
增长率 3
OSCR 的年度增长率数据
指标 趋势 202520242023202220212020
Revenue YoY 5-point trend, -90.8% 27.5% 56.5% 47.9% 115.6% 297.3% ·
Revenue CAGR 3Y 3-point trend, -67.4% 43.5% 70.9% 133.1% · · ·
Revenue CAGR 5Y 90.8% · · · · ·
估值 (TTM) 4
OSCR 的年度估值 (TTM)数据
指标 趋势 202520242023202220212020
Revenue TTM 5-point trend, +536.4% $11.70B $9.18B $5.86B $3.96B $1.84B ·
Net Income TTM 5-point trend, +22.6% $-443M $25M $-271M $-606M $-573M ·
P/E 5-point trend, -246.6% -8.5 134.4 -7.5 -0.9 -2.5 ·
Earnings Yield 5-point trend, +71.1% -11.8% 0.74% -13.3% -115.9% -40.8% ·

财务报表 损益表、资产负债表、现金流量表 — 年度,近5年

损益表
2025-12-312024-12-312023-12-312022-12-312021-12-31
收入 $11.70B$9.18B$5.86B$3.96B$1.84B
营业利润率 % -3.4%0.62%-4.0%-29.6%
净收入 $-443M$25M$-271M$-606M$-573M
稀释后每股收益 (EPS) $-1.69$0.10$-1.22$-2.85$-3.20
资产负债表
2025-12-312024-12-312023-12-312022-12-312021-12-31
负债/股东权益比率 0.40.30.40.0
流动比率 0.90.81.31.2
速动比率 0.60.60.80.6
现金流
2025-12-312024-12-312023-12-312022-12-312021-12-31
自由现金流 $1.06B$950M$-298M$-208M

最新新闻 提及该公司的近期头条新闻

我的指标 您的个人关注列表 — 来自完整基本面的选定行

📊

选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。

您的选择已保存,并会跟随您浏览所有股票。

机构持有人 (13F) 463 家申报者 · $4.5B 总计 · 截至 2026年6月30日

在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。

机构活动 — Q2 2026 与上一季度对比
新仓位 已退出持仓 增加 减少 净股数变动
134 (+60 与上一季度对比) 45 (-19 与上一季度对比) 141 (+17 与上一季度对比) 107 (-4 与上一季度对比) +16.8M

与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。

机构 价值 股份 % 已追踪的13F 类型
VANGUARD PORTFOLIO MANAGEMENT LLC $314559172 11029424 7.01% 股份
VANGUARD CAPITAL MANAGEMENT LLC $301725543 10579437 6.73% 股份
D. E. Shaw & Co., Inc. $259880743 9112228 5.79% 股份
AMERICAN CENTURY COMPANIES INC $258255502 9055242 5.76% 股份
Thrive Capital Management, LLC $180919957 6343617 4.03% 股份
STATE STREET CORP $165454531 5801351 3.69% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $162917648 5712400 3.63% 买入期权
GEODE CAPITAL MANAGEMENT, LLC $141980956 4977203 3.17% 股份
FMR LLC $138622458 4860535 3.09% 股份
TWO SIGMA INVESTMENTS, LP $115097850 4035689 2.57% 股份
BIT Capital GmbH $97480134 3417957 2.17% 股份
DIMENSIONAL FUND ADVISORS LP $94434740 3311177 2.11% 股份
RENAISSANCE TECHNOLOGIES LLC $93673940 3284500 2.09% 股份
JACOBS LEVY EQUITY MANAGEMENT, INC $86282012 3025316 1.92% 股份
JANE STREET GROUP, LLC $74631792 2616823 1.66% 股份
GLYNN CAPITAL MANAGEMENT LLC $73462615 2575828 1.64% 股份
CITADEL ADVISORS LLC $72469320 2541000 1.62% 买入期权
WOLVERINE ASSET MANAGEMENT LLC $61825656 2167800 1.38% 卖出期权
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $60458493 2119863 1.35% 股份
SUSQUEHANNA INTERNATIONAL GROUP, LLP $55351616 1940800 1.23% 卖出期权
JANE STREET GROUP, LLC $53968396 1892300 1.20% 买入期权
BlackBarn Capital Partners LP $49910000 1750000 1.11% 卖出期权
BNP PARIBAS FINANCIAL MARKETS $48660710 1706196 1.08% 股份
VANGUARD FIDUCIARY TRUST CO $45996029 1612764 1.03% 股份
CITADEL ADVISORS LLC $44459828 1558900 0.99% 卖出期权
STATE OF MICHIGAN RETIREMENT SYSTEM $41354000 1450000 0.92% 股份
BANK OF AMERICA CORP /DE/ $36176793 1268471 0.81% 股份
Assenagon Asset Management S.A. $35592732 1247992 0.79% 股份
TWO SIGMA ADVISERS, LP $35534136 2472800 0.79% 股份
JANE STREET GROUP, LLC $33796200 1185000 0.75% 卖出期权
GROUP ONE TRADING LLC $32744154 1148112 0.73% 股份
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $31200652 1093992 0.70% 股份
Qube Research & Technologies Ltd $30913940 1083939 0.69% 股份
TUDOR INVESTMENT CORP ET AL $29055948 1018792 0.65% 股份
GILDER GAGNON HOWE & CO LLC $28576515 1001982 0.64% 股份
GOLDMAN SACHS GROUP INC $26322819 922960 0.59% 股份
Walleye Capital LLC $23243058 814974 0.52% 股份
Point72 Asset Management, L.P. $22809212 799762 0.51% 股份
Walleye Trading LLC $22744700 797500 0.51% 买入期权
FEDERATED HERMES, INC. $22241550 779858 0.50% 股份
Walleye Trading LLC $20594292 722100 0.46% 卖出期权
Balyasny Asset Management L.P. $20211240 708669 0.45% 股份
WOLVERINE TRADING, LLC $19244780 1006000 0.43% 买入期权
MILLENNIUM MANAGEMENT LLC $18292101 641378 0.41% 股份
Halter Ferguson Financial Inc. $17882240 627007 0.40% 股份
CITADEL ADVISORS LLC $17044921 597648 0.38% 股份
Walleye Trading LLC $15952833 559356 0.36% 股份
Caption Management, LLC $15723076 551300 0.35% 卖出期权
WOLVERINE TRADING, LLC $14846793 776100 0.33% 卖出期权
CAPITAL FUND MANAGEMENT S.A. $14807327 519191 0.33% 股份
PFM Health Sciences, LP $14802336 519016 0.33% 股份
CANADA PENSION PLAN INVESTMENT BOARD $14317040 502000 0.32% 股份
WELLS FARGO & COMPANY/MN $14301981 501472 0.32% 股份
Eurizon Capital SGR S.p.A. $13987854 490380 0.31% 股份
RPG Investment Advisory, LLC $13981017 490218 0.31% 股份
TUDOR INVESTMENT CORP ET AL $13977652 490100 0.31% 买入期权
Caption Management, LLC $13769456 482800 0.31% 买入期权
Alphabet Inc. $13746298 481988 0.31% 股份
Swiss National Bank $13501368 473400 0.30% 股份
CREDIT AGRICOLE S A $13119286 460003 0.29% 股份
RBF Capital, LLC $12822706 449604 0.29% 股份
MILLENNIUM MANAGEMENT LLC $12802628 448900 0.29% 卖出期权
Trexquant Investment LP $12674259 444399 0.28% 股份
BlackRock, Inc. $12343114 432788 0.28% 股份
IMC-Chicago, LLC $12036581 422040 0.27% 股份
FORA Capital, LLC $11957021 419030 0.27% 股份
PERCEPTIVE ADVISORS LLC $11408000 400000 0.25% 股份
Connor, Clark & Lunn Investment Management Ltd. $11327203 397167 0.25% 股份
Rhenman & Partners Asset Management AB $11179840 392000 0.25% 股份
SILVERCREST ASSET MANAGEMENT GROUP LLC $10799925 378679 0.24% 股份
UBS Group AG $10607358 371927 0.24% 股份
WELLINGTON MANAGEMENT GROUP LLP $10027661 351601 0.22% 股份
ARDSLEY ADVISORY PARTNERS LP $9982000 350000 0.22% 股份
VICTORY CAPITAL MANAGEMENT INC $9924475 347983 0.22% 股份
Fiduciary Alliance LLC $9802210 343696 0.22% 股份
BCS Private Wealth Management, Inc. $9665000 338885 0.22% 股份
SIMPLEX TRADING, LLC $9283516 325509 0.21% 股份
Squarepoint Ops LLC $9166214 321396 0.20% 股份
SEB Asset Management AB $9085456 318565 0.20% 股份
MARSHALL WACE, LLP $9052762 317418 0.20% 股份
Squarepoint Ops LLC $8906796 312300 0.20% 买入期权
BARCLAYS PLC $8827711 309527 0.20% 股份
Engineers Gate Manager LP $8802185 308632 0.20% 股份
TOWLE & CO $8801186 308597 0.20% 股份
RHUMBLINE ADVISERS $8563598 300267 0.19% 股份
PRUDENTIAL FINANCIAL INC $8412544 294970 0.19% 股份
FIRST TRUST ADVISORS LP $8152727 285860 0.18% 股份
MILLENNIUM MANAGEMENT LLC $7939968 278400 0.18% 买入期权
FRED ALGER MANAGEMENT, LLC $7777290 272696 0.17% 股份
TORONTO DOMINION BANK $7632066 267604 0.17% 股份
BANK OF MONTREAL /CAN/ $7383828 258900 0.16% 卖出期权
General Equity Holdings LP $6844800 240000 0.15% 股份
TD Asset Management Inc $6561311 230060 0.15% 股份
VANGUARD ASSET MANAGEMENT, Ltd $6509690 228250 0.15% 股份
OSAIC HOLDINGS, INC. $6398318 224346 0.14% 股份
AMERIPRISE FINANCIAL INC $6363383 223120 0.14% 股份
Squarepoint Ops LLC $6203100 217500 0.14% 卖出期权
Public Sector Pension Investment Board $6120392 214600 0.14% 股份
Bridgewater Associates, LP $6094838 213704 0.14% 股份
NORGES BANK $5741390 201311 0.13% 股份

公司内部人士 21 位内幕人士 · 10 位高管 · 12 位董事

内部人士 角色 上次活动 持股数量 买入 12个月 卖出 12个月 净额 12个月
Mark T Bertolini Chief Executive Officer 2026年6月30日 S 7751570 1 8 $-58759399
Richard Scott Blackley Chief Financial Officer 2026年6月2日 S 1074977 0 1 $-493628
Janet Liang President, Oscar Insurance 2026年6月2日 S 259057 0 1 $-194356
Meghan V. Joyce Chief Operating Officer 2021年9月1日 M 34669 0 0 $0
Victoria Baltrus Chief Accounting Officer 2026年6月2日 S 214589 0 1 $-23718
Adam Mcananey Chief Legal Officer 2026年6月2日 S 218096 0 1 $-153593
Joshua Kushner Co-Founder and Vice Chairman 2024年11月21日 P 6343617 0 0 $0
Dennis Weaver Chief Clinical Officer 2021年9月1日 M 5323 0 0 $0
Alessandrea C. Quane EVP, Chief Insurance Officer 2021年8月31日 A 0 0 $0
Joel Klein Chief Policy & Strat. Officer 2021年3月5日 A 0 0 0 $0
William Gassen 董事 2026年7月9日 A 82840 0 0 $0
David Plouffe 董事 2026年7月9日 A 137121 0 0 $0
Sid Sankaran 董事 2026年7月9日 A 22609 0 0 $0
Mario Schlosser 董事 2026年7月1日 C 0 0 16 $-32199014
Laura W Lang 董事 2026年6月4日 A 82840 0 0 $0
Vanessa Ames Wittman 董事 2026年6月4日 A 137121 0 0 $0
Jeffery H Boyd 董事 2026年4月9日 A 0 0 $0
Elbert O. Robinson Jr. 董事 2021年3月5日 A 50000 0 0 $0
Teri List-Stoll 董事 2021年3月5日 A 50000 0 0 $0
Jr Charles E Phillips 董事 2021年3月5日 A 50000 0 0 $0
Ari Fischel 2021年3月5日 A 0 0 0 $0

来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖

激进投资者及 5%+ 股东 1 持仓

提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。

申报人 已申报 持股 状态 目的 申报
Thrive Capital Partners II, L.P. (2), Thrive Partners II GP, LLC (2), Thrive Capital Partners III, L.P. (2), Claremount TW, L.P. (2), Thrive Partners III GP, LLC (2), Thrive Capital Partners V, L.P. (2), Claremount V Associates, L.P. (2), Thrive Partners V GP, LLC (2), Thrive Capital Partners VI Growth, L.P. (2), Claremount VI Associates, L.P. (2), Thrive Partners VI GP, LLC (2), Thrive Capital Partners VII Growth, L.P. (2), Thrive Partners VII Growth GP, LLC (2), Claremount VII Associates, L.P. (2), Thrive Partners VII GP, LLC (2), Joshua Kushner (2) ×4 申报 2024年11月13日 初始申报 SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ETF持仓 由 64 只交易所交易基金持有

权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。

基金 权重 单位 截至 来源
HEAL · Global X Funds 4.61% 51902 NS 2026年5月31日 N-PORT
ABLS · Abacus FCF ETF Trust 3.73% 2476 NS 2026年4月30日 N-PORT
CBLS · Elevation Series Trust 2.79% 80448 NS 2026年4月30日 N-PORT
CBSE · Elevation Series Trust 2.79% 72369 NS 2026年4月30日 N-PORT
RNIN · EA Series Trust 1.77% 146523 NS 2026年4月30日 N-PORT
AVUV · AMERICAN CENTURY ETF TRUST 0.53% 6454468 NS 2026年5月31日 N-PORT
CLSE · Trust for Professional Managers 0.48% 132126 NS 2026年5月31日 N-PORT
OASC · Unified Series Trust 0.25% 9324 NS 2026年5月31日 N-PORT
BBSC · J.P. Morgan Exchange-Traded Fund ... 0.19% 74299 NS 2026年4月30日 N-PORT
BKSE · BNY Mellon ETF Trust 0.18% 7801 NS 2026年4月30日 N-PORT
FYC · First Trust Exchange-Traded Alpha... 0.18% 99887 NS 2026年4月30日 N-PORT
RSSL · Global X Funds 0.11% 87779 NS 2026年4月30日 N-PORT
ITWO · ProShares Trust 0.11% 9555 NS 2026年5月31日 N-PORT
DFAS · Dimensional ETF Trust 0.11% 798894 NS 2026年4月30日 N-PORT
SCHA · SCHWAB STRATEGIC TRUST 0.10% 1045927 NS 2026年5月31日 N-PORT
AVLV · AMERICAN CENTURY ETF TRUST 0.10% 576130 NS 2026年5月31日 N-PORT
FYX · First Trust Exchange-Traded Alpha... 0.09% 60366 NS 2026年4月30日 N-PORT
UWM · ProShares Trust 0.07% 7474 NS 2026年5月31日 N-PORT
URTY · ProShares Trust 0.05% 7563 NS 2026年5月31日 N-PORT
AVUQ · AMERICAN CENTURY ETF TRUST 0.05% 5330 NS 2026年5月31日 N-PORT
FNCL · FIDELITY COVINGTON TRUST 0.04% 52605 NS 2026年4月30日 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 0.04% 169 NS 2026年5月31日 N-PORT
FAD · First Trust Exchange-Traded Alpha... 0.04% 9312 NS 2026年4月30日 N-PORT
TILT · FlexShares Trust 0.03% 38192 NS 2026年4月30日 N-PORT
AVMV · AMERICAN CENTURY ETF TRUST 0.03% 8235 NS 2026年5月31日 N-PORT
AVUS · AMERICAN CENTURY ETF TRUST 0.03% 164245 NS 2026年5月31日 N-PORT
FNDA · SCHWAB STRATEGIC TRUST 0.03% 103995 NS 2026年5月31日 N-PORT
MSSM · MORGAN STANLEY PATHWAY FUNDS 0.02% 7591 NS 2026年5月31日 N-PORT
HDG · ProShares Trust 0.02% 190 NS 2026年5月31日 N-PORT
DFAC · Dimensional ETF Trust 0.02% 416676 NS 2026年4月30日 N-PORT
DFSU · Dimensional ETF Trust 0.02% 18514 NS 2026年4月30日 N-PORT
AVMC · AMERICAN CENTURY ETF TRUST 0.02% 2932 NS 2026年5月31日 N-PORT
AVSU · AMERICAN CENTURY ETF TRUST 0.01% 3086 NS 2026年5月31日 N-PORT
DCOR · Dimensional ETF Trust 0.01% 20151 NS 2026年4月30日 N-PORT
DXUV · Dimensional ETF Trust 0.01% 1983 NS 2026年4月30日 N-PORT
DFAU · Dimensional ETF Trust 0.01% 48264 NS 2026年4月30日 N-PORT
SCHB · SCHWAB STRATEGIC TRUST 0.01% 126382 NS 2026年5月31日 N-PORT
DFUS · Dimensional ETF Trust 0.01% 67852 NS 2026年4月30日 N-PORT
AVLC · AMERICAN CENTURY ETF TRUST 0.00% 1834 NS 2026年5月31日 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0.00% 956 NS 2026年5月31日 N-PORT
VXF · VANGUARD INDEX FUNDS 2026年7月15日 每日
VB · VANGUARD INDEX FUNDS 2026年7月15日 每日
VBK · VANGUARD INDEX FUNDS 2026年7月15日 每日
VTI · VANGUARD INDEX FUNDS 2026年7月15日 每日
VT · VANGUARD INTERNATIONAL EQUITY IND... 2026年7月15日 每日
VTWO · VANGUARD SCOTTSDALE FUNDS 2026年7月15日 每日
VTWG · VANGUARD SCOTTSDALE FUNDS 2026年7月15日 每日
VTHR · VANGUARD SCOTTSDALE FUNDS 2026年7月15日 每日
ITOT · iShares Trust 2026年8月5日 每日
IWV · iShares Trust 2026年8月18日 每日